Of note, the BCSH Blood Transfusion Task Force takes the stance that " [i]t is not necessary to irradiate red cells for routine 'top-up' transfusions of premature or term infants.
Based on multiple documented cases of TA-GVHD in this population, the European School of Haematology, the European Group for Blood and Marrow Transplantation, the Foundation for the Accreditation of Cellular Therapy, and the BCSH Blood Transfusion Task Force all recommend irradiated blood products for allogeneic and autologous hematopoietic progenitor cell recipients.
Regarding non-Hodgkin lymphoma, the 2011 BCSH Blood Transfusion Task Force states, "There are relatively few reports of TA-GVHD in non-Hodgkin lymphoma (NHL) and the majority have been in patients with high-grade disease.
The BCSH Blood Transfusion Task Force recommends, "All granulocyte components should be irradiated before issue and transfused with minimum delay.
The BCSH Blood Transfusion Task Force also takes the position that "[i]t is not necessary to irradiate blood components for patients undergoing routine surgery, those with solid tumors, HIV infection, autoimmune diseases or after solid organ transplantation .